These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 33104828)

  • 21. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina.
    Gu L; Xu H; Wang F; Xu G; Sinha D; Wang J; Xu JY; Tian H; Gao F; Li W; Lu L; Zhang J; Xu GT
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):8208-22. PubMed ID: 25335981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
    Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C1q/TNF-Related Protein 3 Prevents Diabetic Retinopathy via AMPK-Dependent Stabilization of Blood-Retinal Barrier Tight Junctions.
    Yan Z; Wang C; Meng Z; Gan L; Guo R; Liu J; Bond Lau W; Xie D; Zhao J; Lopez BL; Christopher TA; Naik UP; Ma X; Wang Y
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269401
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of Diabetes-Induced Lysyl Oxidase Overexpression Prevents Retinal Vascular Lesions Associated With Diabetic Retinopathy.
    Song B; Kim D; Nguyen NH; Roy S
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5965-5972. PubMed ID: 30550614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
    Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
    Kim D; Mecham RP; Nguyen NH; Roy S
    Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
    Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L
    Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.
    Canning P; Glenn JV; Hsu DK; Liu FT; Gardiner TA; Stitt AW
    Exp Diabetes Res; 2007; 2007():51837. PubMed ID: 17641742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin exerts protective effects on diabetic retinopathy via inhibition of Wnt/β-catenin pathway as revealed by quantitative proteomics.
    Yan M; Wang H; Gu Y; Li X; Tao L; Lu P
    Exp Eye Res; 2021 Apr; 205():108521. PubMed ID: 33636209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy.
    Jo DH; Yun JH; Cho CS; Kim JH; Kim JH; Cho CH
    Glia; 2019 Feb; 67(2):321-331. PubMed ID: 30444022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
    Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
    J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases.
    Kim J; Kim CS; Lee YM; Jo K; Shin SD; Kim JS
    Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):691-7. PubMed ID: 22249316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier Breakdown.
    Abu El-Asrar AM; Mohammad G; Nawaz MI; Abdelsaid M; Siddiquei MM; Alam K; Van den Eynde K; De Hertogh G; Opdenakker G; Al-Shabrawey M; Van Damme J; Struyf S
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1956-64. PubMed ID: 25711636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.
    Zhang X; Bao S; Lai D; Rapkins RW; Gillies MC
    Diabetes; 2008 Apr; 57(4):1026-33. PubMed ID: 18174522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
    Lu J; Yao YY; Dai QM; Ma GS; Zhang SF; Cao L; Ren LQ; Liu NF
    Cardiovasc Diabetol; 2012 Sep; 11():105. PubMed ID: 22954171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
    Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
    Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells
    Zhang T; Ouyang H; Mei X; Lu B; Yu Z; Chen K; Wang Z; Ji L
    FASEB J; 2019 Nov; 33(11):11776-11790. PubMed ID: 31365278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural flavonoid galangin alleviates microglia-trigged blood-retinal barrier dysfunction during the development of diabetic retinopathy.
    Zhang T; Mei X; Ouyang H; Lu B; Yu Z; Wang Z; Ji L
    J Nutr Biochem; 2019 Mar; 65():1-14. PubMed ID: 30597356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LECT2 Ameliorates Blood-Retinal Barrier Impairment Secondary to Diabetes Via Activation of the Tie2/Akt/mTOR Signaling Pathway.
    Qin YJ; Xiao K; Zhong Z; Zhao Y; Yu T; Sun XF
    Invest Ophthalmol Vis Sci; 2022 Mar; 63(3):7. PubMed ID: 35262733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation.
    Ibrahim AS; El-Shishtawy MM; Peña A; Liou GI
    Mol Vis; 2010 Oct; 16():2033-42. PubMed ID: 21042558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.